Patient reported outcomes continue to be of increasing importance in assessing efficacy of new pharmaceutical products. Translating these measurements to the electronic world has brought evolving challenges.
This unique conference will address an update to key elements in the adoption of electronic patient reported outcomes (ePRO) for use in the pharmaceutical industry.

KEY TOPICS
•Technology Aspects of the FDA PRO Guidance
•From Paper to Electronic Diaries
•Best Practices for Investigative Sites and Site SOPs
•Selecting an Appropriate ePRO Technology.